|
Contents
|
|
|
|
|
|
|
Brain
Tumors |
|
|
|
|
Antonyak MA, Kenyon LC, Godwin AK, James DC, Emlet DR,
Okamoto I, Tnani M, Holgado-Madruga M, Moscatello DK, Wong AJ.
Elevated JNK activation contributes
to the pathogenesis of human brain tumors
Oncogene 2002 Aug 1;21(33):5038-46
.JPG)
Abstract | .png)
Full Text |
.png)
Reprint
|
|
Kurihara
M, Tokunaga Y, Ochi A, Kawaguchi T, Tsutsumi K, Shigematsu K, Niwa M,
Mori K
Expression
of insulin-like growth factor I receptors in human brain tumors:
comparison with epidermal growth factor receptor by using quantitative
autoradiography
No To Shinkei. 1989 Jul;41(7):719-25
|
|
|
Cancer
Research
|
|
|
|
Clarke K, Smith K, Gullick WJ, Harris AL
Mutant epidermal growth factor receptor enhances
induction of vascular endothelial growth factor by hypoxia and
insulin-like growth factor-1 via a PI3 kinase dependent pathway
Br J Cancer. 2001 May 18;84(10):1322-9
|
|
Resnicoff M, Cui S, Coppola D, Hoek
JB, Rubin R
Ethanol-induced inhibition of cell
proliferation is modulated by insulin-like growth factor-I receptor levels
Alcohol Clin Exp Res. 1996 Aug;20(5):961-6
|
|
|
Gliomas |
|
|
|
J. C.
Buckner, K. D. Aldape, K.
Ballman, B. W. Scheithauer, P. C. Burger, C. Giannini, P. L. Schaefer, R. B.
Jenkins, C. D. James
Immunohistochemical detection of EGFRvIII and
prognostic significance in patients with malignant glioma enrolled in NCCTG
clinical trials
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1508
|
|
T.
Burton, P. Baijal, E. Henson, S. Zhang, S.B. Gibson, and D.D. Eisenstat
The Hypoxia-Inducible Cell Death Gene
BNIP3 In Malignant Gliomas
Society
for Neuro-Oncology Eighth Annual Meeting. Keystone, Colorado. November 13–16,
2003. Abstract No. AN-05.
Neuro-Oncology, Volume 5, CNO 4, October 2003
|
|
Cavenee WK
Genetics and new approaches to cancer therapy
Carcinogenesis, Vol. 23, No. 5, 683-686, May 2002. (PDF Full Text)
|
|
|
Hatanpaa
KJ, Burma S, Zhao D, Habib AA
Epidermal growth factor receptor in glioma: signal transduction,
neuropathology, imaging, and radioresistance
Neoplasia. 2010 Sep;12(9):675-84
Abstract |
Full Text |
Reprint | .gif)
Related articles
|
|
|
Larysz
D, Kula D, Kowal M, Rudnik A, Jarząb
M, Blamek S, Bierzyńska-Macyszyn
G, Kowalska M, Bażowski
P, Jarząb
B.
Epidermal growth factor receptor gene expression in high grade gliomas.
Folia Neuropathol. 2011;49(1):28-38. Epub 2011 Mar 31.
Abstract |
Reprint |
Related articles
|
|
Marie Y, Carpentier AF, Omuro AM, Sanson M, Thillet J, Hoang-Xuan K,
Delattre JY
EGFR tyrosine kinase domain mutations in human
gliomas
Neurology.
2005 Apr 26;64(8):1444-5
|
|
|
Soeda A, Inagaki A, Oka N, Ikegame Y, Aoki H,
Yoshimura SI, Nakashima S, Kunisada T, Iwama T
Epidermal growth factor plays a crucial role in mitogenic regulation of
human brain tumor stem cells
J Biol Chem. 2008 Feb 20; [Epub ahead of print]
Abstract |
Reprint
|
|
Vollmann A, Vornlocher H-P,
Geick A, Spruss T, Apfel R, Giegerich G, Bogdahn U
RNAi
mediated effective inhibition of EGFP and EGF-R gene expression in
malignant glioma
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 737
|
|
|
Glioblastoma |
|
|
|
Marc
A. Brockmann, Ulrike Ulbricht, Regina Fillbrandt, Manfred Westphal,
and Katrin Lamszus
Stimulation
Of Glioblastoma And Cerebral Microvascular Endothelial Cell Migration By
Tumor-Associated Growth Factors
Society for
Neuro-Oncology Eighth Annual Meeting. Keystone, Colorado. November
13–16, 2003. Abstract No. AN-04.
Neuro-Oncology, Volume 5, CNO 4, October 2003
|
|
Chakravarti A, Loeffler JS, Dyson NJ
Insulin-like growth factor receptor I mediates
resistance to anti-epidermal growth factor receptor therapy in primary human
glioblastoma cells through continued activation of phosphoinositide 3-kinase
signaling
Cancer Res 2002 Jan 1;62(1):200-7
|
|
|
Gan
HK, Kaye AH, Luwor RB
The EGFRvIII variant in glioblastoma multiforme
J Clin Neurosci. 2009 Mar 24;. [Epub ahead of print]
Abstract
|
|
Gillaspy GE, Mapstone TB, Samols D,
Goldthwait DA
Transcriptional patterns of growth factors and
proto-oncogenes in human glioblastomas and normal glial cells
Cancer Lett. 1992 Jul 31;65(1):55-60
|
|
B. K.
Kleinschmidt-DeMasters, MD; K. O.
Lillehei, MD; M. Varella-Garcia, PhD
Glioblastomas in the Older
Old
Arch
Pathol Lab Med. 2005 May;129(5):624-631. (HTML & PDF Full Text)
|
|
Penar
PL, Khoshyomn S, Bhushan A, Tritton TR
Inhibition
of epidermal growth factor receptor-associated tyrosine kinase blocks
glioblastoma invasion of the brain
Neurosurgery
1997 Jan;40(1):141-51
|
|
|
Deepti B. Ramnarain,
Seongmi Park, Diana Y. Lee, Kimmo J.
Hatanpaa, Shane O. Scoggin, Hasan Otu, Towia
A. Libermann, Jack M. Raisanen, Raheela Ashfaq,
Eric T. Wong, Julian Wu, Robert Elliott
and Amyn A. Habib
Differential Gene Expression
Analysis Reveals Generation of an Autocrine Loop by a Mutant Epidermal
Growth Factor Receptor in Glioma Cells
Cancer Research, 66, 867-874, January 15, 2006
Abstract
| BrainLife
| .gif)
News
|
|
Saito T, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F,
Arifin MT, Arita K, Kurisu K.
Prognosis of cerebellar glioblastomas: correlation between prognosis and
immunoreactivity for epidermal growth factor receptor compared with
supratentorial glioblastomas.
Anticancer Res. 2006
Mar-Apr;26(2B):1351-7.
Abstract
|
|
|
Metastatic
Tumors |
|
|
|
Nichon L.
Grupka, MD, Kelly C. Lear-Kaul, MD, Bette
K. Kleinschmidt-DeMasters, MD, and Meenakshi Singh, MD
Epidermal Growth Factor Receptor Status in Breast Cancer
Metastases to the Central Nervous System. Comparison With HER-2/neu
Status
Arch of Path and Laboratory Medicine, Vol.
128, No. 9, Sept 2004, pp. 974–979. (PDF Full Text)
|
|
|
Non-CNS Tumors |
|
|
|
Jianmin
Chen, P. Mark Stavro,
Lilian U. Thompson
Dietary Flaxseed Inhibits Human Breast Cancer Growth and
Metastasis and Downregulates Expression of Insulin-Like Growth Factor and
Epidermal Growth Factor Receptor
Nutrition and Cancer, Volume: 43 Number: 2 Page: 187 -- 192 (2002)
|
|
M.W.
Pedersen, V. Tkach, N. Pedersen, V. Berezin, H.S. Poulsen
A
naturally occurring constitutively active variant of the epidermal growth factor
receptor increases cell motility
ECCO 12 - the European
Cancer Conference Copenhagen, Denmark, 21-25 September 2003.
Abstract No. 625
European Journal of
Cancer Supplements; Vol. 1, No. 5, September 2003, page S188
|
|
